JP2003525251A5 - - Google Patents

Download PDF

Info

Publication number
JP2003525251A5
JP2003525251A5 JP2001563137A JP2001563137A JP2003525251A5 JP 2003525251 A5 JP2003525251 A5 JP 2003525251A5 JP 2001563137 A JP2001563137 A JP 2001563137A JP 2001563137 A JP2001563137 A JP 2001563137A JP 2003525251 A5 JP2003525251 A5 JP 2003525251A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
polypeptide
zcyto7
expression
schwann cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001563137A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003525251A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2001/006294 external-priority patent/WO2001064240A2/en
Publication of JP2003525251A publication Critical patent/JP2003525251A/ja
Publication of JP2003525251A5 publication Critical patent/JP2003525251A5/ja
Pending legal-status Critical Current

Links

JP2001563137A 2000-02-29 2001-02-27 シュワン細胞によるミエリンの産生を促進するための方法 Pending JP2003525251A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US51522300A 2000-02-29 2000-02-29
US09/515,223 2000-02-29
PCT/US2001/006294 WO2001064240A2 (en) 2000-02-29 2001-02-27 Methods for promoting production of myelin by schwann cells

Publications (2)

Publication Number Publication Date
JP2003525251A JP2003525251A (ja) 2003-08-26
JP2003525251A5 true JP2003525251A5 (cg-RX-API-DMAC7.html) 2008-04-17

Family

ID=24050447

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001563137A Pending JP2003525251A (ja) 2000-02-29 2001-02-27 シュワン細胞によるミエリンの産生を促進するための方法

Country Status (5)

Country Link
EP (1) EP1259253A2 (cg-RX-API-DMAC7.html)
JP (1) JP2003525251A (cg-RX-API-DMAC7.html)
AU (1) AU2001241816A1 (cg-RX-API-DMAC7.html)
CA (1) CA2401716A1 (cg-RX-API-DMAC7.html)
WO (1) WO2001064240A2 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040234500A1 (en) * 2001-03-26 2004-11-25 Moore Emma E. Method for inducing proliferation of retinal stem cells
JP2010509364A (ja) * 2006-11-08 2010-03-25 ザイモジェネティクス, インコーポレイテッド 創傷治癒における使用のためのil−17b
JP7214081B2 (ja) 2014-09-12 2023-01-30 ザ アドミニストレイターズ オブ ザ テューレイン エデュケイショナル ファンド 神経ミクロ生理学的システム及びこれを使用する方法
CA3023451A1 (en) 2016-05-06 2017-11-09 Exicure, Inc. Liposomal spherical nucleic acid (sna) constructs presenting antisense oligonucleotides (aso) for specific knockdown of interleukin 17 receptor mrna
WO2018201090A1 (en) 2017-04-28 2018-11-01 Exicure, Inc. Synthesis of spherical nucleic acids using lipophilic moieties
CN120392966B (zh) * 2025-07-01 2025-10-21 华中科技大学同济医学院附属协和医院 糖尿病周围神经病变靶向治疗的药物及调控雪旺细胞增殖功能的神经保护药物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000073452A2 (en) * 1999-06-02 2000-12-07 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
US5707829A (en) * 1995-08-11 1998-01-13 Genetics Institute, Inc. DNA sequences and secreted proteins encoded thereby
EP0839196B1 (en) * 1995-07-19 2005-05-11 Genetics Institute, LLC Human ctla-8 and uses of ctla-8-related proteins
CN1258315A (zh) * 1997-04-25 2000-06-28 津莫吉尼蒂克斯公司 哺乳动物细胞因子样因子7
AU8571198A (en) * 1997-07-16 1999-02-10 Human Genome Sciences, Inc. Interleukin-20
ES2333772T3 (es) * 1999-12-23 2010-03-01 Genentech, Inc. Polipeptidos homologos de il-17 y il-17r y sus utilizaciones terapeuticas.

Similar Documents

Publication Publication Date Title
JP2003505347A5 (cg-RX-API-DMAC7.html)
JP2009537143A5 (cg-RX-API-DMAC7.html)
JP2003500040A5 (cg-RX-API-DMAC7.html)
JP2004511201A5 (cg-RX-API-DMAC7.html)
JP2003522514A5 (cg-RX-API-DMAC7.html)
DE502004012225D1 (de) Generierung künstlicher bindungsproteine auf der grundlage von ubiquitin-proteinen
JP2002513556A5 (cg-RX-API-DMAC7.html)
JP2003527079A5 (cg-RX-API-DMAC7.html)
NZ601544A (en) Combination therapy for the treatment of ocular neovascular disorders
JP2004501101A5 (cg-RX-API-DMAC7.html)
RU2000124084A (ru) Химерное антитело, которое связывается с CD40 человека (варианты), молекула нуклеиновой кислоты (варианты), вектор экспрессии (варианты), гуманизированное антитело (варианты), фармацевтическая композиция для лечения заболевания, опосредованного Т-клетками (варианты), способ лечения больного от заболевания, опосредованного Т-клетками (варианты)
WO1995021919A3 (en) Protein having tpo activity
JP2002527052A5 (cg-RX-API-DMAC7.html)
JP2008503217A5 (cg-RX-API-DMAC7.html)
JP2006526414A5 (cg-RX-API-DMAC7.html)
JP2002542827A5 (cg-RX-API-DMAC7.html)
JP2003504062A5 (cg-RX-API-DMAC7.html)
JP2005506275A5 (cg-RX-API-DMAC7.html)
JP2004531242A5 (cg-RX-API-DMAC7.html)
JP2001526242A5 (cg-RX-API-DMAC7.html)
EP1969003B8 (en) Uses of a NEUROTROPHIC FACTOR PROTEIN
JP2002522512A5 (cg-RX-API-DMAC7.html)
JP2005512518A5 (cg-RX-API-DMAC7.html)
JP2002539827A5 (cg-RX-API-DMAC7.html)
JP2008532995A (ja) 組換え高効率複合インターフェロンの使用方法